Aigen Investment Management’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-13,840
| Closed | -$197K | – | 998 |
|
|
2023
Q4 | $197K | Buy |
+13,840
| New | +$197K | 0.04% | 669 |
|
|
2023
Q1 | – | Sell |
-83,491
| Closed | -$1.3M | – | 826 |
|
|
2022
Q4 | $1.3M | Buy |
+83,491
| New | +$1.3M | 0.18% | 144 |
|
|
2022
Q3 | – | Sell |
-94,747
| Closed | -$1.33M | – | 753 |
|
|
2022
Q2 | $1.33M | Buy |
94,747
+70,191
| +286% | +$985K | 0.22% | 134 |
|
|
2022
Q1 | $352K | Sell |
24,556
-264
| -1% | -$3.78K | 0.06% | 338 |
|
|
2021
Q4 | $337K | Buy |
+24,820
| New | +$337K | 0.02% | 753 |
|
|
2021
Q3 | – | Sell |
-36,261
| Closed | -$610K | – | 652 |
|
|
2021
Q2 | $610K | Sell |
36,261
-3,989
| -10% | -$67.1K | 0.11% | 201 |
|
|
2021
Q1 | $735K | Buy |
+40,250
| New | +$735K | 0.1% | 223 |
|
|
2020
Q3 | – | Sell |
-167,092
| Closed | -$3M | – | 1101 |
|
|
2020
Q2 | $3M | Buy |
167,092
+134,296
| +409% | +$2.41M | 0.38% | 46 |
|
|
2020
Q1 | $498K | Buy |
32,796
+8,468
| +35% | +$129K | 0.07% | 418 |
|
|
2019
Q4 | $480K | Buy |
+24,328
| New | +$480K | 0.08% | 326 |
|